Polyethylene glycol recombinant human somatropin

(Jintrolong, 金赛增^®) Approved

A pegylated recombinant human growth hormone (GH) used to treat pediatric growth retardation.

Research Code GenSci-004

CAS No. 1088845-67-3

Efmoroctocog alfa/Efraloctocog alfa

(Elocta, Eloctate^®) Approved

A recombinant Fc-human blood coagulation factor VIII fusion protein indicated for the treatment and prevention of bleeding in patients with hemophilia A.

Research Code BIIB-031; rFVIIIFc

CAS No. 1270012-79-7

Chidamide

(Epidaza, 爱谱沙^®) Approved

A histone deacetylase (HDAC) inhibitor used to treat recurrent or refractory peripheral T cell lymphoma (PTCL).

Research Code HBI-8000; CS-055; CS-02100055; 87CIC980Y0 (UNII code)

CAS No. 743438-44-0(Chidamide)

Simoctocog alfa/Antihemophilic Factor (Recombinant)

(Nuwiq, Vihuma^®) Approved

A recombinant coagulation factor VIII indicated for the treatment and prevention of bleeding in patients with hemophilia A.

Research Code Human-cl rhFVIII; Factor VIII 

CAS No. 1219013-68-9

Ataluren

(Translarna^®) Approved

A nonsense mutations regulator used to treat Duchenne muscular dystrophy.

Research Code PTC-124

CAS No. 775304-57-9(Ataluren)

Eliglustat Tartrate

(Cerdelga^®) Approved

A glucosylceramide synthase (UGCG) inhibitor used to treat type 1 Gaucher's disease (GD1).

Research Code Genz-112638; Genz-99067

CAS No. 928659-70-5(Eliglustat Tartrate)  491833-29-5(Eliglustat)

Vaniprevir

(Vanihep^®) Approved

A HCV NS3/4A protease (NS3/NS4A) inhibitor used to treat HCV infection.

Research Code MK-7009

CAS No. 923590-37-8(Vaniprevir)

Ripasudil Hydrochloride Hydrate

(Glanatec^®) Approved

A Rho kinase (RhoK) inhibitor used to treat glaucoma and ocular hypertension.

Research Code K-115; K-115-R

CAS No. 887375-67-9(Ripasudil HCl Dihydrate)  223645-67-8(Ripasudil)

Follitropin alfa biosimilar (Finox Biotech)

(Bemfola^®) Approved

A recombinant human follicle stimulating hormone (FSH) used in women undergoing controlled ovarian stimulation during infertility treatment and hypogonadotropic hypogonadism in men.

Research Code

CAS No. 146479-72-3

Vorapaxar Sulfate

(Zontivity^®) Approved

A protease-activated receptor-1 (PAR-1) antagonist used to reduce thrombotic cardiovascular events with myocardial infarction (MI) or with peripheral arterial disease (PAD).

Research Code SCH-530348; MK-5348; TRA-SCH-530348

CAS No. 705260-08-8(Vorapaxar Sulfate)  618385-01-6(Vorapaxar)

Oritavancin Diphosphate

(Orbactiv, Nuvocid^®) Approved

A novel semisynthetic glycopeptide antibiotic (Cell wall biosynthesis inhibitor) used for treatment of serious gram-positive bacterial infections.

Research Code LY-333328; LY-333328 diphosphate; ORBACTIV

CAS No. 192564-14-0(Oritavancin Diphosphate)  171099-57-3(Oritavancin )

Finafloxacin

(Xtoro^®) Approved

A quinolone antibiotic (DNA gyrase and topoisomerase IV inhibitor) used to treat acute otitis externa (AOE).

Research Code AL-60371; BY-377; EXE-844; EXE-844b

CAS No. 209342-40-5(Finafloxacin)

Tofogliflozin Hydrate

(Deberza, Apleway^®) Approved

A sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes.

Research Code CSG-452; R-7201; RG-7201; RO4998452

CAS No. 1201913-82-7(Tofogliflozin Monohydrate)  903565-83-3(Tofogliflozin)

Antihemophilic Factor (Recombinant), Porcine Sequence

(Obizur^®) Approved

A recombinant porcine coagulation factor VIII indicated for the treatment of bleeding episodes in adults with acquired hemophilia A.

Research Code BAX-802; BAX-801; OBI-1

CAS No.

Vedolizumab

(Entyvio^®) Approved

An integrin α4β7 antagonist used to treat adult ulcerative colitis and adult Crohn's disease.

Research Code MLN-002; MLN-0002; MLN-02; LPD-02; LDP-02; Anti-beta7-MAb

CAS No. 943609-66-3

Morinidazole

(迈灵达^®) Approved

A nitroimidazoles antibiotic used to treat sensitive anaerobic bacterial infections including appendicitis and pelvic inflammatory disease.

Research Code

CAS No. 92478-27-8(Morinidazole)

Phenothrin

(Sumithrin^®) Approved

A synthetic pyrethroid used to treat keratinocytes type scabies and nail scabies.

Research Code KC-1001

CAS No. 26002-80-2(Phenothrin)

Luseogliflozin Hydrate

(Lusefi^®) Approved

A sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes.

Research Code TS-071; TS-71

CAS No. 898537-18-3(Luseogliflozin)

Insulin human (inhalation powder)

(Afrezza, Afresa, Technosphere Insulin System^®) Approved

A rapid acting inhaled insulin used to improve glycemic control in adult patients with diabetes mellitus.

Research Code SAR-439065

CAS No. 11061-68-0 (Recombinant insulin Human)

Insulin glargine

(Basaglar, Abasaglar, Abasria^®) Approved

A long-acting human insulin analog used to improve glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes.

Research Code LY-2963016; LY2963016-U-100; LY2963016-U-200

CAS No. 160337-95-1